Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - cloxacillin as the benzathine salt - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 600.0 mg/5.4gs - antibiotic & related - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - corynebacterium spp. | mastitis | organisms sensitive to cloxacillin | staphylococcus spp. | streptococcus spp. | bacterial canker | staphylococcosis | subclinical mastitis

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - cloxacillin as the benzathine salt - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 200.0 mg/sg - antibiotic & related - cattle lactating | bovine - mastitis | subclinical mastitis

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - ampicillin trihydrate; cloxacillin as the benzathine salt - misc. intra mammary - ampicillin trihydrate antibiotic active 300.0 mg/sg; cloxacillin as the benzathine salt antibiotic active 600.0 mg/sg - antibiotic & related - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - corynebacterium pyogenes | mastitis | staphylococcus spp. | streptococcus agalactiae | staphylococcosis | subclinical mastitis

Spojené štáty - angličtina - NLM (National Library of Medicine)

merck sharp & dohme corp. - cloxacillin benzathine (unii: ac79l7pv2g) (cloxacillin - unii:o6x5qgc2vb) - cloxacillin 500 mg in 7.5 ml - indications: orbenin-dc is indicated in the treatment and prophylaxis of bovine mastitis in nonlactating cows due to staphylococcus aureus and streptococcus agalactiae . contraindications: because cloxacillin benzathine is relatively insoluble, orbenin-dc's activity will be prolonged. therefore, orbenin-dc should not be used for the occasional cow which may have a dry period of less than 4 weeks. this precaution will avoid residues in the milk following removal of the colostrum.

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - cloxacillin as the benzathine salt - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 200.0 mg/3gsy - antibiotic & related - cattle lactating | bovine - mastitis | subclinical mastitis

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - cloxacillin as the benzathine salt - topical cream, ointment, paste, gel, lotion - cloxacillin as the benzathine salt antibiotic active 833.0 mg/5gtub - ophthalmic preparations - cat | cattle | dog | horse | sheep | beef | bitch | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castra - bacterial kerato conjunctivitis | organisms sensitive to cloxacillin | pink-eye

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - ampicillin as the trihydrate; cloxacillin as the benzathine salt - misc. intra mammary - ampicillin as the trihydrate antibiotic active 300.0 mg/sg; cloxacillin as the benzathine salt antibiotic active 600.0 mg/sg - antibiotic & related - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - corynebacterium pyogenes | mastitis | staphylococcus spp. | streptococcus agalactiae | staphylococcosis | subclinical mastitis

Spojené štáty - angličtina - NLM (National Library of Medicine)

physicians total care, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - the penicillinase-resistant penicillins are indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drugs. cultures and susceptibility tests should be performed initially to determine the causative organism and their sensitivity to the drug (see clinical pharmacology – susceptibility testing ). the penicillinase-resistant penicillins may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of laboratory test results. the penicillinase-resistant penicillins should not be used in infections caused by organisms susceptible to penicillin g. if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus, therapy should not be continued with a penicillinase-resistant penicillin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dic

Spojené štáty - angličtina - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 500 mg - the penicillinase-resistant penicillins are indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drugs. cultures and susceptibility tests should be performed initially to determine the causative organism and their sensitivity to the drug (see clinical pharmacology – susceptibility testing ). the penicillinase-resistant penicillins may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of laboratory test results. the penicillinase-resistant penicillins should not be used in infections caused by organisms susceptible to penicillin g. if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus, therapy should not be continued with a penicillinase-resistant penicillin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dic

Spojené štáty - angličtina - NLM (National Library of Medicine)

rebel distributors corp - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin sodium 250 mg - the penicillinase-resistant penicillins are indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drugs. cultures and susceptibility tests should be performed initially to determine the causative organism and their sensitivity to the drug (see clinical pharmacology – susceptibility testing ). the penicillinase-resistant penicillins may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of laboratory test results. the penicillinase-resistant penicillins should not be used in infections caused by organisms susceptible to penicillin g. if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus, therapy should not be continued with a penicillinase-resistant penicillin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dic